EGFR inhibitor C225 increases the radiosensitivity of human lung squamous cancer cells

7Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: The purpose of the present study is to investigate the direct biological effects of the epidermal growth factor receptor (EGFR) inhibitor C225 on the radiosensitivity of human lung squamous cancer cell-H520. H520 cells were treated with different dosage of 60Co γ ray irradiation (1.953 Gy/min) in the presence or absence of C225. The cellular proliferation, colony forming capacity, apoptosis, the cell cycle distribution as well as caspase-3 were analyzed in vitro.Results: We found that C225 treatment significantly increased radiosensitivity of H-520 cells to irradiation, and led to cell cycle arrest in G1phase, whereas 60Co γ ray irradiation mainly caused G2phase arrest. H-520 cells thus displayed both the G1and G2phase arrest upon treatment with C225 in combination with 60Co γ ray irradiation. Moreover, C225 treatment significantly increased the apoptosis percentage of H-520 cells (13.91% ± 1.88%) compared with the control group (5.75% ± 0.64%, P < 0.05).Conclusion: In this regard, C225 treatment may make H-520 cells more sensitive to irradiation through the enhancement of caspase-3 mediated tumor cell apoptosis and cell cycle arrest. © 2010 Zhang et al; licensee BioMed Central Ltd.

Cite

CITATION STYLE

APA

Zhang, Y., Wang, J., Liu, F., You, Z., Yang, R., & Zhao, Y. (2010). EGFR inhibitor C225 increases the radiosensitivity of human lung squamous cancer cells. Cancer Cell International, 10. https://doi.org/10.1186/1475-2867-10-39

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free